MedTrace Logo

Observational Study of Sifrol® in Patients With Primary Restless Legs Syndrome (RLS)

NCT02248155 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2644

Last updated 2014-09-25

No results posted yet for this study

Summary

The objectives of this Post Marketing Surveillance (PMS) are:

* Evaluation of the treatment effect of pramipexole on Restless Legs Syndrome (RLS) severity as measured by International Restless Legs Syndrome Scale (IRLS) and Clinical Global Impression Improvement scale (CGI- I)
* Evaluation of the time to reaching maintenance dose of pramipexole
* Evaluation of work productivity impairment associated with RLS based on the Work Productivity and Activity Impairment Questionnaire (WPAI) questionnaire

Conditions

  • Restless Legs Syndrome

Interventions

DRUG

Pramipexole

Sponsors & Collaborators

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2006-11-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02248155 on ClinicalTrials.gov